ROYAL LONDON ASSET MANAGEMENT LTD – Regeneron Pharmaceuticals, Inc. Transaction History
ROYAL LONDON ASSET MANAGEMENT LTD portfolio value:
$24.14M
portfolio value
ROYAL LONDON ASSET MANAGEMENT LTD quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -3.59% | -1.30K shares | 2.66M | $688.87 | 35.02K |
Q2 2022 | share | Increase | +0.88% | 316 shares | -3.68M | $591.13 | 36.32K |
Q1 2022 | share | Increase | +5.35% | 1.83K shares | 3.56M | $698.42 | 36.01K |
Q4 2021 | share | Decrease | -1.73% | -602 shares | 555K | $642.51 | 34.18K |
Q3 2021 | share | Increase | +1.49% | 512 shares | 1.89M | $605.18 | 34.78K |
Q2 2021 | share | Decrease | -5.14% | -1.85K shares | 2.05M | $558.54 | 34.27K |
Q1 2021 | share | Increase | +2.82% | 990 shares | 130K | $473.14 | 36.13K |
Q4 2020 | share | Decrease | -6.07% | -2.27K shares | -4.50M | $483.11 | 35.14K |
Q3 2020 | share | Decrease | -0.09% | -32 shares | -1.39M | $559.78 | 37.41K |
Q2 2020 | share | Increase | +18.04% | 5.72K shares | 7.85M | $623.65 | 37.44K |
Q1 2020 | share | Decrease | -0.45% | -143 shares | 3.10M | $488.29 | 31.72K |
Q4 2019 | share | Decrease | -0.72% | -231 shares | 3.00M | $375.48 | 31.86K |
Q3 2019 | share | Increase | +0.66% | 210 shares | -1.07M | $277.4 | 32.09K |
Q2 2019 | share | Decrease | -1.21% | -389 shares | -3.27M | $313 | 31.88K |
Q1 2019 | share | Decrease | -5.07% | -1.72K shares | 924K | $410.62 | 32.27K |
Q4 2018 | share | Increase | +5.78% | 1.85K shares | -661K | $373.5 | 33.99K |
Q3 2018 | share | Decrease | -4.46% | -1.49K shares | 1.38M | $404.04 | 32.14K |
Q2 2018 | share | Increase | +22.29% | 6.13K shares | 1.99M | $344.99 | 33.64K |
Q2 2016 | share | Decrease | -99.61% | -7.06M shares | -10.39M | $349.23 | 27.50K |
Q1 2016 | share | Increase | +24466.83% | 7.06M shares | 4.17M | $360.44 | 7.09M |